[]
Logo
Quick Enquiry

Tafamidis Impurities and its Related Products

Home > Impurities > Tafamidis > Product Listing of Tafamidis Impurities
Displaying 5 results of Tafamidis Impurities

Tafamidis Impurities are the unwanted substances present in Tafamidis, a medication used to treat a rare genetic disease called transthyretin amyloidosis. These impurities can affect the efficacy and safety of the drug and may cause adverse effects. Therefore, it is important to identify, monitor and control these impurities to ensure the quality, safety, and potency of the medication.


2-(2-chlorophenyl)-1,3-benzoxazole-5-carboxylic acid

TAFAMIDIS IMPURITIES, IMPURITIES
2-(2-chlorophenyl)-1,3-benzoxazole-5-carboxylic acid

CAT No. : CS-ED-00868
Mol F. : C14H8ClNO3
Mol W. : 273.67 g/mol
Cas No. : 1018498-30-0
Stock : Enquire
2-(3,4-Dichlorophenyl)-6-benzoxazolecarboxylic acid

TAFAMIDIS IMPURITIES, IMPURITIES
2-(3,4-Dichlorophenyl)-6-benzoxazolecarboxylic acid

CAT No. : CS-O-40353
Mol F. : C14H7Cl2NO3
Mol W. : 308.12 g/mol
Cas No. : 1507158-86-2
Stock : Enquire
4-[(3,5-dichlorobenzoyl)amino]-3-hydroxybenzoic acid

TAFAMIDIS IMPURITIES, IMPURITIES
4-[(3,5-dichlorobenzoyl)amino]-3-hydroxybenzoic acid

CAT No. : CS-O-40351
Mol F. : C14H9Cl2NO4
Mol W. : 326.13 g/mol
Cas No. : 1184581-58-5
Stock : Enquire
methyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate

TAFAMIDIS IMPURITIES, IMPURITIES
methyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate

CAT No. : CS-O-40400
Mol F. : C15H9Cl2NO3
Mol W. : 322.1 g/mol
Cas No. : 1395964-06-3
Stock : Enquire
Tafamidis meglumine

TAFAMIDIS IMPURITIES, IMPURITIES
Tafamidis meglumine

CAT No. : CS-N-05179
Mol F. : C21H24Cl2N2O8
Mol W. : 503.33 g/mol
Cas No. : 951395-08-7
Stock : Enquire